Thomas Clozel – Co-Founder and CEO, OWKIN

Thomas Clozel, co-founder and CEO of OWKIN, elaborates on how AI can be applied to the pharmaceutical industry to revolutionize today’s drug discovery and development process. He also comments on the challenges facing the sector and how OWKIN is well positioned to overcome questions such as data privacy.  
The big question in AI is how to get data and who the data belongs to
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report